Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases.

Allergic rhinitis and asthma are inflammatory airway allergic diseases caused by Th2-driven immune response. Several studies have shown that multipotent adipose-derived stem cells (ASCs) can exert profound immunosuppressive effects via modulation of both cellular and innate immune pathway, especially immunosuppressive effect on T cell activities. ASCs' ability to be readily isolated from a number of adipose tissues and expanded ex vivo makes them attractive candidate for use in clinical therapy in the context of allogeneic transplantation, in particular to modulate graft-versus-host disease and graft rejection. The authors have investigated whether ASCs can inhibit Th2-dependent airway allergic disease in the mouse model. In this article we review recent experimental data and discuss about the mechanisms by which ASCs inhibit allergic airway inflammation via immunomodulation from a Th2 to a Th1-biased response in the mouse model.

[1]  J. Cohen,et al.  A Role for Mesenchymal Stem Cells in the Control of Graft-Versus-Host Disease , 2009, Transplantation.

[2]  F. Dazzi,et al.  The Immunosuppressive Properties of Mesenchymal Stem Cells , 2009, Transplantation.

[3]  H. Mizuno.  Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. , 2009, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[4]  J. Jung,et al.  IFATS Collection: Immunomodulatory Effects of Adipose Tissue‐Derived Stem Cells in an Allergic Rhinitis Mouse Model , 2009, Stem cells.

[5]  S. McTaggart,et al.  Immunosuppression by mesenchymal stromal cells: from culture to clinic. , 2008, Experimental hematology.

[6]  L. Moretta,et al.  Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. , 2008, Blood.

[7]  N. Rouas-Freiss,et al.  Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells , 2008, Stem cells.

[8]  J. Ryan,et al.  Interferon‐γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells , 2007 .

[9]  Yilin Cao,et al.  Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. , 2007, Tissue engineering.

[10]  S. Beyth,et al.  Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling. , 2007, Experimental hematology.

[11]  E. Lam,et al.  Mesenchymal Stem Cells Inhibit Dendritic Cell Differentiation and Function by Preventing Entry Into the Cell Cycle , 2007, Transplantation.

[12]  R. Yañez,et al.  Adipose Tissue‐Derived Mesenchymal Stem Cells Have In Vivo Immunosuppressive Properties Applicable for the Control of the Graft‐Versus‐Host Disease , 2006, Stem cells.

[13]  A. Uccelli,et al.  Immunoregulatory function of mesenchymal stem cells , 2006, European journal of immunology.

[14]  J. Gimble,et al.  The Immunogenicity of Human Adipose‐Derived Cells: Temporal Changes In Vitro , 2006, Stem cells.

[15]  Hermann Eichler,et al.  Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue , 2006, Stem cells.

[16]  L. Moretta,et al.  Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. , 2006, Blood.

[17]  Sergio Romagnani,et al.  Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .

[18]  A. Wheeler,et al.  Modern approaches to therapeutic vaccination as treatment for Type 1 respiratory hypersensitivity (allergy) treatment , 2006, Expert review of vaccines.

[19]  R. Maizels,et al.  Suppression of allergic airway inflammation by helminth-induced regulatory T cells , 2005, The Journal of experimental medicine.

[20]  Yi Zhang,et al.  Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. , 2005, Blood.

[21]  R. Cancedda,et al.  Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway , 2005, European journal of immunology.

[22]  E. Lam,et al.  Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. , 2005, Blood.

[23]  L. Pénicaud,et al.  Immunomodulatory effect of human adipose tissue‐derived adult stem cells: comparison with bone marrow mesenchymal stem cells , 2005, British journal of haematology.

[24]  D. Mevorach,et al.  Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. , 2005, Blood.

[25]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[26]  Y. Bae,et al.  Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue , 2004, Cellular Physiology and Biochemistry.

[27]  Moustapha Hassan,et al.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.

[28]  Lauren Cohn,et al.  Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.

[29]  A. Togias.  Rhinitis and asthma: evidence for respiratory system integration. , 2003, The Journal of allergy and clinical immunology.

[30]  M. Krampera,et al.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.

[31]  L. Boulet,et al.  The relationships between atopy, rhinitis and asthma: pathophysiological considerations , 2003, Current opinion in allergy and clinical immunology.

[32]  P. Hellings,et al.  Allergic rhinitis and asthma: the link further unraveled , 2003, Current opinion in pulmonary medicine.

[33]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2002, Nature.

[34]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[35]  Y. Sung,et al.  The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma. , 2001, The Journal of allergy and clinical immunology.

[36]  David Skoner,et al.  Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. , 2001, The Journal of allergy and clinical immunology.

[37]  A B Kay,et al.  Allergy and allergic diseases. First of two parts. , 2001, The New England journal of medicine.

[38]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[39]  A. Kaplan,et al.  Allergy and allergic diseases. , 2008 .

[40]  Kazuya Sato,et al.  Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. , 2007, Blood.

[41]  F. Benvenuto,et al.  Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.

[42]  Kevin McIntosh,et al.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.